布地奈德/福莫特罗干粉吸入剂治疗儿童哮喘的有效性和安全性

	［1］Global Strateg for Asthma Management and Prevention. Global Initiative for Asthma (GINA)［EB/OL］.［2008-12-24］.
	［2］Bateman ED, Bantje TA, Joao Gomes M, Toumbis MG, Huber RM, Naya I, et al. Combination therapy with single inhaler budesonide/formaterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma ［J］.Am J Respir Med, 2003, 2(3)：275-281.
	［3］陈育智.儿童支气管哮喘的诊断与治疗［M］.北京：人民卫生出版社，2004, 101-106.
	［4］Brattsand R, Miller-Larsson A. The role of intracellular esterification in budesonide once-daily dosing and airway selectivity［J］. Clin Ther, 2003, 25(Suppl C):C28-C41.
	［5］Balanag VM, Yunus F, Yang PＣ, Jorup C. Budesonide/formoterol in a single inhaler is as effective and well tolerated as salbutamol in relieving acute asthma in adults and adolescents［J］. Eur Respir J, 2003, 22(Suppl 45):445s.
	［6］Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting bata2-agonists and corticosteroids［J］. Eur Respir J, 2002, 19(1):182-191.
	［7］Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma［J］. Curr Med Res Opin, 2004, 20(9):1403-1418.
	［8］Bames PJ. Scientific rationale for using a single inhaler for asthma control［J］. Eur Respir J, 2007, 29(3)：587-595.